Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.53 |
| ▸ | ABCC8 | Q09428 | 3/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.53 |
| ▸ | HTR2A | P28223 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.53 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.53 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.53 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.53 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.53 |
| ▸ | MC4R | P32245 | 12/20 | 0.47 |
| ▸ | MC5R | P33032 | 4/20 | 0.47 |
| ▸ | MC3R | P41968 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6081074 | 0.90 | ABCC8 (0.53) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6081218 | 0.90 | CYP3A4 (0.53) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6080539 | 0.88 | ABCC8 (0.64) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6080962 | 0.88 | ABCC8 (0.63) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6081412 | 0.84 | ABCC8 (0.51) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6080988 | 0.83 | ABCC8 (0.56) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6080947 | 0.82 | CYP3A4 (0.63) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6080796 | 0.81 | CNR2 (0.47) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6081182 | 0.81 | LMNA (0.55) | CYP3A4ABCC8ABCB11HTR2ALMNA | |
| SCHEMBL6080924 | 0.81 | ABCC8 (0.62) | CYP3A4ABCC8ABCB11HTR2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060079696-A1 | Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses | GENFIT (FR) | 2006-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079696-A1 | Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses | AADAC, NAT1, PARN | CYP3A4 208/4885ABCC8 567/4885ABCB11 70/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.